ATE191928T1 - Zellzyklus- kontrollzusammensetzungen und methoden diese zu benutzen. - Google Patents

Zellzyklus- kontrollzusammensetzungen und methoden diese zu benutzen.

Info

Publication number: ATE191928T1
Authority: AT; Austria
Prior art keywords: cell cycle; cell; methods; cycle control; protein
Prior art date: 1991-10-17

Application number

AT92924108T

Other languages

English (en)

Inventor

Wen-Hwa Lee

Eva Y H P Lee

David W Goodrich

Nang-Ping Wang

Original Assignee

Univ California

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-10-17

Filing date

1992-10-16

Publication date

2000-05-15

1992-10-16 Application filed by Univ California filed Critical Univ California

2000-05-15 Application granted granted Critical

2000-05-15 Publication of ATE191928T1 publication Critical patent/ATE191928T1/de

Links

239000000203 mixture Substances 0.000 title abstract 3
230000022983 regulation of cell cycle Effects 0.000 title 1
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
102000004169 proteins and genes Human genes 0.000 abstract 3
108090000623 proteins and genes Proteins 0.000 abstract 3
230000006369 cell cycle progression Effects 0.000 abstract 2
239000012634 fragment Substances 0.000 abstract 2
230000022131 cell cycle Effects 0.000 abstract 1
230000001276 controlling effect Effects 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
230000016507 interphase Effects 0.000 abstract 1
230000001105 regulatory effect Effects 0.000 abstract 1
230000035899 viability Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cell Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Microbiology (AREA)
Toxicology (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Steroid Compounds (AREA)
Cosmetics (AREA)

AT92924108T 1991-10-17 1992-10-16 Zellzyklus- kontrollzusammensetzungen und methoden diese zu benutzen. ATE191928T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US77851091A	1991-10-17	1991-10-17
PCT/US1992/008918 WO1993008267A1 (en)	1991-10-17	1992-10-16	Cell cycle controlling compositions and methods of using same

Publications (1)

Publication Number	Publication Date
ATE191928T1 true ATE191928T1 (de)	2000-05-15

Family

ID=25113590

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92924108T ATE191928T1 (de)	1991-10-17	1992-10-16	Zellzyklus- kontrollzusammensetzungen und methoden diese zu benutzen.

Country Status (11)

Country	Link
EP (1)	EP0610420B1 (de)
JP (2)	JP3450006B2 (de)
KR (1)	KR100279797B1 (de)
AT (1)	ATE191928T1 (de)
AU (1)	AU679431B2 (de)
CA (1)	CA2120353C (de)
DE (1)	DE69230943T2 (de)
ES (1)	ES2148181T3 (de)
NO (1)	NO315895B1 (de)
TW (1)	TW346397B (de)
WO (1)	WO1993008267A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0666312A1 (de) *	1994-02-08	1995-08-09	Wolfgang A. Renner	Verfahren zur Förderung des Wachstums von Säugetierzellen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1341576C (en) *	1986-08-11	2008-07-08	Thaddeus P. Dryja	Diagnosis of retinoblastoma
US4942123A (en)	1987-09-17	1990-07-17	The Regents Of The University Of California	ppRB110 -phosphoprotein the retinoblastoma susceptibility gene product
AU3038189A (en) *	1988-01-21	1989-08-11	Massachusetts Eye And Ear Infirmary	Diagnosis of retinoblastoma
JPH03505675A (ja)	1988-10-31	1991-12-12	ザリージェンツオブザユニヴァーシティオブカリフォルニア	新生表現型の抑制を制御する産生体及び方法
ZA909755B (en) *	1989-12-07	1991-09-25	Res Dev Foundation	Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product

1992
- 1992-04-17 TW TW081103034A patent/TW346397B/zh not_active IP Right Cessation
- 1992-10-16 AT AT92924108T patent/ATE191928T1/de not_active IP Right Cessation
- 1992-10-16 CA CA002120353A patent/CA2120353C/en not_active Expired - Fee Related
- 1992-10-16 WO PCT/US1992/008918 patent/WO1993008267A1/en not_active Ceased
- 1992-10-16 KR KR1019940701258A patent/KR100279797B1/ko not_active Expired - Fee Related
- 1992-10-16 DE DE69230943T patent/DE69230943T2/de not_active Expired - Fee Related
- 1992-10-16 EP EP92924108A patent/EP0610420B1/de not_active Expired - Lifetime
- 1992-10-16 AU AU30546/92A patent/AU679431B2/en not_active Ceased
- 1992-10-16 JP JP50786393A patent/JP3450006B2/ja not_active Expired - Fee Related
- 1992-10-16 ES ES92924108T patent/ES2148181T3/es not_active Expired - Lifetime
1994
- 1994-04-15 NO NO19941377A patent/NO315895B1/no unknown
2003
- 2003-04-04 JP JP2003102318A patent/JP2003277290A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
NO941377D0 (no)	1994-04-15
AU679431B2 (en)	1997-07-03
EP0610420B1 (de)	2000-04-19
CA2120353C (en)	2008-04-29
JP3450006B2 (ja)	2003-09-22
DE69230943T2 (de)	2000-11-30
CA2120353A1 (en)	1993-04-29
NO941377L (no)	1994-06-10
DE69230943D1 (de)	2000-05-25
TW346397B (en)	1998-12-01
JP2003277290A (ja)	2003-10-02
WO1993008267A1 (en)	1993-04-29
EP0610420A1 (de)	1994-08-17
JPH07504805A (ja)	1995-06-01
ES2148181T3 (es)	2000-10-16
AU3054692A (en)	1993-05-21
NO315895B1 (no)	2003-11-10
KR100279797B1 (ko)	2001-04-02

Similar Documents

Publication	Publication Date	Title
BR9608114A (pt)	2000-10-31	Vacinas de pertussis a celular e processos para preparação das mesmas
ATE43635T1 (de)	1989-06-15	Verfahren zur herstellung von interferon und expressionsvektoren dafuer.
EP0377836A3 (de)	1990-10-24	Verfahren und Mittel zur Haarpflege
DE69230789D1 (de)	2000-04-20	Methoden zur behandlung von durch den tumor nekrose faktor ausgelösten krankheiten
ATE96678T1 (de)	1993-11-15	Verfahren zur verminderung von hautirritationen bei anwendung von durchdringungsverstaerkenden arzneimittelzusammensetzungen.
DK322188A (da)	1988-12-17	Fremgangsmaade til fremstilling af protein
ES2018923A6 (es)	1991-05-16	Un metodo para producir microparticulas dispersables en agua de proteina insoluble en agua.
PT923293E (pt)	2005-03-31	Tratamento da diarreia
DK0572688T3 (da)	1997-12-01	Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi
DE69101634D1 (de)	1994-05-11	Rekombinant hergestellte blutfaktoren, verfahren zur exprimierung besagter blutfaktoren sowie in besagtem prozess verwendeter rekombinanter vaccina-virus.
EP0009206A3 (en)	1980-04-16	Fluor-containing 1,4-dihydropyridines, process for their preparation and their application in pharmaceuticals
EP0751954A4 (de)	1998-06-03	Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
DE69510356D1 (de)	1999-07-22	Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie
DK0419878T3 (da)	1994-11-21	Nye aprotinin-varianter og genteknologisk fremgangsmåde til mikrobiel fremstilling af disse varianter i homogent processeret form
DE69230943D1 (de)	2000-05-25	Zellzyklus- Kontrollzusammensetzungen und Methoden diese zu benutzen.
DE60026883D1 (de)	2006-05-11	Methoden und zusammensetzungen zur behandlung von schmerzen
HUT66153A (en)	1994-09-28	Pharmaceutical compositions which can be used for preventing and treating of chemotherapy-induced alopecia
BG101125A (en)	1998-02-27	Low molecular biologically active substance of yeasts and method for its preparation
EP0145486A3 (de)	1986-10-08	Mikrobiologisches Verfahren
DK0658117T3 (da)	1999-02-01	Behandling af tumorer med neurotrofe faktorer og celleproliferationsinhibitorer
DE69615685D1 (de)	2001-11-08	Impstoff gegen krankheitserreger, zusammensetzung zur behandlung und vorbeugung von hiv infektionen
NO940406L (no)	1994-03-28	Preparat og fremgangsmåte for behandling av sårskader
EP0195087A4 (de)	1988-06-08	Zyklische doppelsträngige dns, deren h2rstellung, mikroorganismen, die diese enthalten, verfahren zur herstellung von einer antigen-determinanten stelle des poliovirus-kapsids aufweisenden proteins und protein-vp1 unter verwendung derselben.
ATE163344T1 (de)	1998-03-15	Zusammensetzungen zur behandlung von geernteter pflanzenmaterial
JPS5218827A (en)	1977-02-12	Soil-treating agents for the control of white ants and method of apply ing the same

Legal Events

Date	Code	Title	Description
2000-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties